RESUMEN

The PAX5 gene, which encodes the B-cell specific activator protein, is one of the most important factors in determination of B-cell development. This gene is the main target of somatic mutations in acute B lymphoblastic leukemia (B-ALL). For example, point mutations, deletions, as well as other gene rearrangements may lead to several forms of B-cell malignancy. In this study, we obtained 50 blood samples from patients diagnosed with ALL, and screened for PAX5 mutations using sequencing in exons 1, 2 and 3. We found a heterozygous germline variant, c.113G>A (p.Arg38His), which affects the paired domain of PAX5. It seems that this mutation is pathogenic, but is recessive. Our findings suggest that this mutation in a single allele of the PAX5 gene is not sufficient to cause disease, and it is possible that other alleles are also involved in the onset of B-ALL.

Asunto(s)

Leucemia de Células B/genética , Mutación Missense/genética , Factor de Transcripción PAX5/genética , Adolescente , Adulto , Linfocitos B/metabolismo , Linfocitos B/patología , Niño , Preescolar , Exones/genética , Femenino , Mutación de Línea Germinal , Heterocigoto , Humanos , Lactante , Irán , Leucemia de Células B/patología , Masculino